Search

Your search keyword '"PAULY, MARK V."' showing total 990 results
Start Over Author "PAULY, MARK V."
990 results on '"PAULY, MARK V."'

1. The Lawyerization of Medicine

Author

Hammer, Peter J., Haas-Wilson, Deborah, Sage, William M., Peterson, Mark A., Pauly, Mark V., and Fuchs, Victor R.

Published
2003

2. Part V: Response by Professor Arrow

Author

Hammer, Peter J., Haas-Wilson, Deborah, Sage, William M., Peterson, Mark A., Pauly, Mark V., and Fuchs, Victor R.

Published
2003

3. Reflections on the Reflections

Author

Hammer, Peter J., Haas-Wilson, Deborah, Sage, William M., Peterson, Mark A., Pauly, Mark V., and Fuchs, Victor R.

Published
2003

4. Cover

Author

Hammer, Peter J., Haas-Wilson, Deborah, Sage, William M., Peterson, Mark A., Pauly, Mark V., and Fuchs, Victor R.

Published
2003

6. Index

Author

Hammer, Peter J., Haas-Wilson, Deborah, Sage, William M., Peterson, Mark A., Pauly, Mark V., and Fuchs, Victor R.

Published
2003

10. Arrow on Trust

Author

Hammer, Peter J., Haas-Wilson, Deborah, Sage, William M., Peterson, Mark A., Pauly, Mark V., and Fuchs, Victor R.

Published
2003

14. The Market for Medical Ethics

Author

Hammer, Peter J., Haas-Wilson, Deborah, Sage, William M., Peterson, Mark A., Pauly, Mark V., and Fuchs, Victor R.

Published
2003

18. The End of Asymmetric Information

Author

Hammer, Peter J., Haas-Wilson, Deborah, Sage, William M., Peterson, Mark A., Pauly, Mark V., and Fuchs, Victor R.

Published
2003

26. Valuing Charity

Author

Hammer, Peter J., Haas-Wilson, Deborah, Sage, William M., Peterson, Mark A., Pauly, Mark V., and Fuchs, Victor R.

Published
2003

33. Preface

Author

Hammer, Peter J., Haas-Wilson, Deborah, Sage, William M., Peterson, Mark A., Pauly, Mark V., and Fuchs, Victor R.

Published
2003

34. Foreword

Author

Hammer, Peter J., Haas-Wilson, Deborah, Sage, William M., Peterson, Mark A., Pauly, Mark V., and Fuchs, Victor R.

Published
2003

35. Foreword

Author

Pauly, Mark V.

Published
2001

39. Cost-Effectiveness Analysis of Branded Drugs With Market Demand and Insurance

Author

Pauly, Mark V, Comanor, William S, Frech, HE, and Martinez, Joseph R

Subjects
Economics, Applied Economics, Econometrics, Cost Effectiveness Research, Health Services, Clinical Research, Comparative Effectiveness Research, Cost-Benefit Analysis, Humans, Insurance, Health, Pharmaceutical Preparations, branded drugs, cost-effectiveness analysis, insurance, Public Health and Health Services, Health Policy & Services, Applied economics, Health services and systems, Policy and administration
Abstract

ObjectivesCost-effectiveness analysis of branded pharmaceuticals presumes that both cost (or price) and marginal effectiveness levels are exogenous. This assumption underlies most judgments of the cost-effectiveness of specific drugs. In this study, we show the theoretical implications of letting both factors be endogenous by modeling pharmaceutical price setting with and without health insurance, along with patient response to the prices that depend on marginal effectiveness. We then explore the implications of these models for cost-effectiveness ratios.MethodsWe used simple textbook models of patient demand and pricing behavior of drug firms to predict market equilibria in the drug and insurance markets and to generate calculations of the cost-effectiveness ratios in those settings.ResultsWe found that ratios in market settings can be much different from those calculated in cost-effectiveness studies based on exogenous prices and treatment of all patients at risk rather than those who would demand treatment in a market setting. We also found that there may be considerable similarity in these market cost-effectiveness ratios across different products because drug firms with market power set profit-maximizing prices.ConclusionsWe found that market cost-effectiveness ratios will always indicate an excess of benefits over cost. Insurance will lead to less favorable ratios than without insurance, but when insurers bargain with drug firms, rather than taking their prices as given, cost-effectiveness ratios will be more favorable.

Published
2021

41. Older Adult and Family Caregiver Perspectives on Engagement in Primary Care

Author

Hirschman, Karen B., Rivera, Eleanor, Sefcik, Justine S., McCauley, Kathleen, Hanlon, Alexandra L., Pauly, Mark V., Press, Matthew J., and Naylor, Mary D.

Subjects
Medical care -- Utilization, Patients -- Care and treatment, Aged patients -- Care and treatment, Caregivers -- Beliefs, opinions and attitudes -- Services, Health, Seniors
Abstract

The purpose of the current in-depth qualitative study was to explore the experiences of older adults and family caregivers in primary care. Twenty patients and caregivers from six Comprehensive Primary Care Plus (CPC+) practices' Patient and Family Advisory Councils within a large academic health system participated in telephone interviews from December 2018 to May 2019. Participants were mostly women (60%), with an average age of 71 years and nine chronic conditions. Transcripts were coded using conventional content analysis. Two key themes emerged related to person-centered care (PCC): Engagement in Health Care and Patient–Provider Relationship. Engagement in health care was defined by participants as: being proactive, centering on patient goals in treatment discussions, adherence, and self-triaging. Approximately all participants discussed the importance of the relationship and interactions with their provider as influencing their engagement. The identified themes offer recommendations for further improvement of primary PCC. [Journal of Gerontological Nursing, 48(11), 7–13.], The patient-centered medical home (PCMH) is among the few care management approaches that have targeted chronically ill adults and demonstrated improvements in multiple dimensions of patients' health, while decreasing costs. [...]

Published
2022
Full Text
View/download PDF

42. Equity Investment in Physician Practices: What's All This Brouhaha?

Author

Pauly, Mark V. and Burns, Lawton Robert

Subjects
*HEALTH services accessibility, *PROFIT, *PUBLIC sector, *INVESTMENTS, *MEDICAL care, *HEALTH policy, *PRIVATE sector, *HEALTH care reform, *PHYSICIANS, *ECONOMIC competition, *MEDICAL care costs, *MEDICAL practice, *ECONOMICS
Abstract

There have been two waves of equity-based investment in physician practices. Both used a combination of public and private sources but in different mixes. The first investment wave, in the 1990s, was led by public equity and physician practice management companies, with less involvement by private equity (PE). The second investment wave followed the Affordable Care Act and was led by PE firms. It has generated concerns of wasteful spending, less cost-effective care, and initiatives harmful to patient welfare. This article compares the two waves and asks if they are parallel in important ways. It describes the similarities in the players, driving forces, acquisition dynamics, spurs to consolidation, types of equity involved, models to organize physicians, and levels of market penetration achieved. The article then tackles three unresolved issues: Does PE investment differ from other investment vehicles in concerning ways? Does PE possess capabilities that other investment vehicles lack and confer competitive advantage? Does physician practice investment offer opportunities for supernormal profits? It then discusses ongoing trends that may disrupt PE and curtail its practice investment. It concludes that past may be prologue, that is, what happened during the 1990s may well repeat, suggesting the PE threat is overblown. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results